Diamond 2005 — Intranasal PT-141 + Sildenafil in ED

Urology

Diamond LE, Earle DC, Garcia WD, Spana C

Summary

Used intranasal route, later discontinued for CV safety

Study Details

Study Design

Randomized, placebo-controlled crossover

Indication

Male ED

Intervention

Intranasal PT-141 7.5 mg + sildenafil 25 mg

Species

Human

Sample Size

19 subjects

Risk of Bias Assessment

Small n; industry-sponsored